Adverum Biotechnologies I...

NASDAQ: ADVM · Real-Time Price · USD
2.82
0.05 (1.81%)
At close: Aug 15, 2025, 3:59 PM
2.81
-0.35%
After-hours: Aug 15, 2025, 06:04 PM EDT

Adverum Biotechnologies Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-183.87M -153.16M -130.93M -94.11M -99.86M -112.9M -117.17M -126.19M -133.43M -145.68M -154.54M -156.21M -154.44M -155.01M -145.54M -148.76M -138.17M -123.04M
Depreciation & Amortization
2.92M 3.34M 3.65M 3.85M 4.47M 5.05M 5.64M 6.35M 6.63M 6.7M 6.53M 6.14M 5.31M 4.9M 4.64M 4.4M 4.62M 4.72M
Stock-Based Compensation
11.44M 12.96M 14.35M 15.22M 16.65M 17.17M 17.57M 18.67M 18.79M 19.26M 20.08M 19.24M 20.06M 23.35M 25.19M 26.96M 27.66M 24.21M
Other Working Capital
15.8M 12.94M 10.79M -1.96M -7.09M -9.47M -7.95M 1.69M 12.78M 16.36M 17.61M 14.63M 11.43M 8.6M 5.67M 8.71M 3.98M 5.84M
Other Non-Cash Items
19.85M 11.63M 9.93M -2.03M 3.51M 16.95M 18.55M 10.89M 3.33M -735K -1.1M -634K 1.3M 137K -25K -82K n/a 81K
Deferred Income Tax
n/a n/a n/a -6.47M -6.55M -7.26M -7.26M -790K -715K n/a n/a 488K 2.44M 2.98M 3.83M 4.98M 2.69M 1.9M
Change in Working Capital
18.75M 13.24M 10.53M -2.08M -6.63M -10.82M -8.32M 3.02M 9.46M 16.73M 18.78M 13.39M 13.76M 9.19M 4.06M 8.26M -1.79M 4.15M
Operating Cash Flow
-130.91M -111.99M -92.46M -85.62M -88.41M -91.81M -90.98M -88.05M -95.94M -101.57M -108.09M -115.43M -109.42M -114.45M -107.83M -104.24M -104.99M -87.98M
Capital Expenditures
-622K -518K -388K -519K -793K -813K -808K -801K -1.13M -7.53M -11.82M -15.98M -20.88M -18.09M -15.12M -12.2M -9.57M -9.04M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-54.43M -74.96M -101.9M -99.26M -65.93M -43.42M -36.72M -42.81M -66.92M -94.84M -104.36M -161.02M -265.23M -354.6M -407.51M -386.82M -450.65M -525.32M
Sales Maturities Of Investments
100.7M 86.9M 60.4M 52.2M 50.69M 97.55M 134.4M 152.6M 183.21M 181.24M 257.9M 340.37M 435.58M 529.2M 501.35M 465.42M 383.78M 331.51M
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
45.65M 11.42M -41.89M -47.58M -16.04M 53.31M 96.88M 108.99M 115.16M 78.87M 141.72M 163.37M 149.47M 156.51M 78.71M 66.4M -76.44M -202.84M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -240K -272K -301K -274K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a 264K 403K 403K 297K 41K -98K 144K 4.55M 4.91M 4.91M 5.04M 740K 904K 952K 1.23M 1.79M 4.07M
Financial Cash Flow
359K 123K 120M 120.01M 119.9M 120.03M 145K 145K 4.55M 4.91M 4.91M 5.04M 740K 895K 2.4M 2.4M 206.65M 208.87M
Net Cash Flow
-84.9M -100.45M -14.35M -12.52M 16.13M 82.2M 6.72M 21.08M 19.46M -22.1M 34.24M 48.68M 40.79M 42.95M -26.73M -35.44M 25.22M -81.96M
Free Cash Flow
-131.53M -112.51M -92.85M -86.14M -89.2M -92.62M -91.79M -88.85M -97.07M -109.1M -119.91M -131.41M -130.3M -132.55M -122.95M -116.44M -114.56M -97.02M